{{Rsnum
|rsid=7536563
|Gene=FAM69A
|Chromosome=1
|position=92883489
|Orientation=plus
|GMAF=0.343
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=FAM69A
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 10.6 | 48.7 | 40.7
| HCB | 0.0 | 8.8 | 91.2
| JPT | 0.0 | 7.1 | 92.9
| YRI | 38.8 | 51.7 | 9.5
| ASW | 19.3 | 64.9 | 15.8
| CHB | 0.0 | 8.8 | 91.2
| CHD | 0.0 | 14.7 | 85.3
| GIH | 9.9 | 34.7 | 55.4
| LWK | 42.7 | 43.6 | 13.6
| MEX | 8.8 | 45.6 | 45.6
| MKK | 35.9 | 52.6 | 11.5
| TSI | 9.9 | 44.6 | 45.5
| HapMapRevision=28
}}[[rs7536563]] has been reported in a large study to be associated with [[multiple sclerosis]].

The risk allele (oriented to the dbSNP entry) is (A); the odds ratio associated with this allele is 1.12 (CI 1.06-1.18). {{PMID|17660530}}

{{PharmGKB
|RSID=rs7536563
|Name_s=
|Gene_s=FAM69A
|Feature=
|Evidence=PubMed ID:17660530
|Annotation=In a replicated GWAS of U.K. and U.S. case/parent trios, this variant was shown to be associated with multiple sclerosis risk.
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Curated
|PharmGKB Accession ID=PA162356166
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs7536563
|overall_frequency_n=76
|overall_frequency_d=128
|overall_frequency=0.59375
|n_genomes=45
|n_genomes_annotated=0
|n_haplomes=65
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}